Your search returned 19 results.

Results
	1.	Informative dropout modeling of longitudinal ordered categorical data and model validation: application to exposure-response modeling of physician's global assessment score for ustekinumab in patients with psoriasis. [electronic resource] by Hu, Chuanpu Szapary, Philippe O Yeilding, Newman Zhou, Honghui Producer: 20110714 In: Journal of pharmacokinetics and pharmacodynamics vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Bounded outcome score modeling: application to treating psoriasis with ustekinumab. [electronic resource] by Hu, Chuanpu Yeilding, Newman Davis, Hugh M Zhou, Honghui Producer: 20111107 In: Journal of pharmacokinetics and pharmacodynamics vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Population-based exposure-efficacy modeling of ustekinumab in patients with moderate to severe plaque psoriasis. [electronic resource] by Zhou, Honghui Hu, Chuanpu Zhu, Yaowei Lu, Ming Liao, Sam Yeilding, Newman Davis, Hugh M Producer: 20100525 In: Journal of clinical pharmacology vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy. [electronic resource] by Gee, Michael S Procopio, William N Makonnen, Sosina Feldman, Michael D Yeilding, Newman M Lee, William M F Producer: 20030124 In: The American journal of pathology vol. 162 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. [electronic resource] by Krueger, Gerald G Langley, Richard G Leonardi, Craig Yeilding, Newman Guzzo, Cynthia Wang, Yuhua Dooley, Lisa T Lebwohl, Mark Producer: 20070212 In: The New England journal of medicine vol. 356 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Population pharmacokinetic modeling of ustekinumab, a human monoclonal antibody targeting IL-12/23p40, in patients with moderate to severe plaque psoriasis. [electronic resource] by Zhu, Yaowei Hu, Chuanpu Lu, Ming Liao, Sam Marini, Joseph C Yohrling, Jennifer Yeilding, Newman Davis, Hugh M Zhou, Honghui Producer: 20090324 In: Journal of clinical pharmacology vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendations. [electronic resource] by Lebwohl, Mark Yeilding, Newman Szapary, Philippe Wang, Yuhua Li, Shu Zhu, Yaowei Reich, Kristian Langley, Richard G Papp, Kim A Producer: 20101013 In: Journal of the American Academy of Dermatology vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). [electronic resource] by Leonardi, Craig L Kimball, Alexa B Papp, Kim A Yeilding, Newman Guzzo, Cynthia Wang, Yuhua Li, Shu Dooley, Lisa T Gordon, Kenneth B Producer: 20080527 In: Lancet (London, England) vol. 371 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. [electronic resource] by Kimball, Alexa B Szapary, Philippe Mrowietz, Ulrich Reich, Kristian Langley, Richard G You, Yin Hsu, Ming-Chun Yeilding, Newman Rader, Daniel J Mehta, Nehal N Producer: 20120820 In: Journal of the American Academy of Dermatology vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives. [electronic resource] by Yeilding, Newman Szapary, Philippe Brodmerkel, Carrie Benson, Jacqueline Plotnick, Michael Zhou, Honghui Goyal, Kavitha Schenkel, Brad Giles-Komar, Jill Mascelli, Mary Ann Guzzo, Cynthia Producer: 20110607 In: Annals of the New York Academy of Sciences vol. 1222 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives--an update. [electronic resource] by Yeilding, Newman Szapary, Philippe Brodmerkel, Carrie Benson, Jacqueline Plotnick, Michael Zhou, Honghui Goyal, Kavitha Schenkel, Brad Giles-Komar, Jill Mascelli, Mary Ann Guzzo, Cynthia Producer: 20121015 In: Annals of the New York Academy of Sciences vol. 1263 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials. [electronic resource] by Lebwohl, Mark Leonardi, Craig Griffiths, Christopher E M Prinz, Jörg C Szapary, Philippe O Yeilding, Newman Guzzo, Cynthia Li, Shu Hsu, Ming-Chun Strober, Bruce Producer: 20120605 In: Journal of the American Academy of Dermatology vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up. [electronic resource] by Reich, Kristian Papp, Kim A Griffiths, Christopher E M Szapary, Philippe O Yeilding, Newman Wasfi, Yasmine Ott, Elyssa Hsu, Ming-Chun Lebwohl, Mark Gordon, Kenneth B Producer: 20120628 In: Journal of drugs in dermatology : JDD vol. 11 Availability: No items available. Save to lists Add to cart (remove)
	14.	Positive treatment effects of ustekinumab in psoriasis: analysis of lesional and systemic parameters. [electronic resource] by Reddy, Manjula Torres, Gisela McCormick, Thomas Marano, Colleen Cooper, Kevin Yeilding, Newman Wang, Yuhua Pendley, Charles Prabhakar, Uma Wong, Jackson Davis, Cuc Xu, Stephen Brodmerkel, Carrie Producer: 20101004 In: The Journal of dermatology vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	A multicenter, randomized, open study to evaluate the impact of an electronic data capture system on the care of patients with rheumatoid arthritis. [electronic resource] by Huffstutter, Joseph Craig, W David Schimizzi, Gregory Harshbarger, John Lisse, Jeffrey Kasle, Shelley Hymson, Lisa Yocum, David Castro, Lesley Hegedus, Ronald Callegari, Peter Yeilding, Newman Gilmer, Keith Producer: 20071017 In: Current medical research and opinion vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). [electronic resource] by Papp, Kim A Langley, Richard G Lebwohl, Mark Krueger, Gerald G Szapary, Philippe Yeilding, Newman Guzzo, Cynthia Hsu, Ming-Chun Wang, Yuhua Li, Shu Dooley, Lisa T Reich, Kristian Producer: 20080527 In: Lancet (London, England) vol. 371 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trials. [electronic resource] by Gordon, Kenneth B Papp, Kim A Langley, Richard G Ho, Vincent Kimball, Alexa B Guzzo, Cynthia Yeilding, Newman Szapary, Philippe O Fakharzadeh, Steven Li, Shu Hsu, Ming-Chun Reich, Kristian Producer: 20120605 In: Journal of the American Academy of Dermatology vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. [electronic resource] by Griffiths, Christopher E M Strober, Bruce E van de Kerkhof, Peter Ho, Vincent Fidelus-Gort, Roseanne Yeilding, Newman Guzzo, Cynthia Xia, Yichuan Zhou, Bei Li, Shu Dooley, Lisa T Goldstein, Neil H Menter, Alan Producer: 20100125 In: The New England journal of medicine vol. 362 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study. [electronic resource] by Furst, Daniel E Gaylis, Norman Bray, Vance Olech, Ewa Yocum, David Ritter, Jeffrey Weisman, Michael Wallace, Daniel J Crues, John Khanna, Dinesh Eckel, Gregory Yeilding, Newman Callegari, Peter Visvanathan, Sudha Rojas, Jeannie Hegedus, Ronald George, Laura Mamun, Khalid Gilmer, Keith Troum, Orrin Producer: 20071025 In: Annals of the rheumatic diseases vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)